(Q47273234)

13 January 2018

title

Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment (English)

1 reference

13 January 2018

1 reference

O Lang

1

1 reference

13 January 2018

E Liebermeister

series ordinal

2

1 reference

13 January 2018

J Liesegang

series ordinal

3

1 reference

13 January 2018

M L Sautter-Bihl

series ordinal

4

1 reference

13 January 2018

publication date

1 December 1998

1 reference

13 January 2018

Strahlentherapie und Onkologie

published in

1 reference

13 January 2018

volume

174

1 reference

13 January 2018

issue

12

1 reference

13 January 2018

page(s)

629-632

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/bf03038511

exact match

0 references

cites work

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

Accelerated hyperfractionated radiotherapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03038511

Epidermal Growth Factor Receptor 425 Monoclonal Antibodies Radiolabeled with Iodine-125 in the Adjuvant Treatment of High-Grade Astrocytomas

21 January 2018

1 reference

12 December 2020

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

[Intraoperative radiotherapy (IORT) in malignant brain tumors]

1 reference

12 December 2020

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

12 December 2020

[Dose-time optimization in fractionated radiotherapy]

1 reference

12 December 2020

Glioblastoma therapy by direct intralesional administration of I-131 radioiodine labeled antitenascin antibodies.

1 reference

12 December 2020

High dose radiation therapy in the treatment of malignant gliomas: Final Report

1 reference

12 December 2020

Radiotherapy of glioblastoma: is shortening of the treatment time justifiable?

1 reference

12 December 2020

Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.

1 reference

12 December 2020

Short-term irradiation of glioblastomas with high-dose single fractions

1 reference

12 December 2020

Intraoperative radiation therapy in malignant glioma: early clinical results.

1 reference

12 December 2020

Hyperthermia--its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors

1 reference

12 December 2020

Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study

1 reference

12 December 2020

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

1 reference

12 December 2020

Therapeutic irradiation and brain injury

1 reference

12 December 2020

Neutron radiotherapy for malignant gliomas.

1 reference

12 December 2020

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

12 December 2020

[Heavy particle radiotherapy at the University of California Lawrence Berkeley Laboratory. Clinical studies by the Northern California Oncology Group]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03038511

1 reference

13 January 2018

1 reference

13 January 2018